McKesson, US58155Q1031

McKesson committed USD 1.4 billion as McKesson stock costs EUR 878.00

Published on 10/15/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson will hold 49 percent of Option Care after its USD 1.4 billion commitment. McKesson stock costs EUR 878.00 on October 15, 2026.

Option Care investment and reporting date

  • McKesson will hold 49 percent of Option Care after the October 6, 2026 agreement.
  • The transaction carries an enterprise value of USD 5.8 billion.
  • McKesson stock traded at EUR 878.00 at 10:08 a.m. CEST at Lang & Schwarz on October 15, 2026.
Architektur-Render eines modernen Hauptsitz-Gebäudes symbolisiert McKesson Corporation ISIN US58155Q1031 im Gesundheitssektor mit großer Glasfassade, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) committed USD 1.4 billion for a 49 percent minority stake in Option Care Health under an agreement announced on October 6, 2026, according to McKesson. The transaction gives investors a concrete test of the company's expansion into specialty healthcare services.

USD 5.8 billion changes the mix

The agreement values Option Care at an enterprise value of USD 5.8 billion, with Clayton, Dubilier & Rice holding approximately 51 percent and McKesson holding approximately 49 percent after closing. Option Care will remain separately managed, while McKesson retains a framework to acquire its partner's interest later, subject to conditions and regulatory approvals, the company said on October 6, 2026.

McKesson's first-quarter fiscal 2027 revenue was USD 105.38 billion, up 7.70 percent from the prior-year quarter, while adjusted earnings per share reached USD 9.93. The figures show the scale against which the new investment will be judged. Yahoo Finance reported those first-quarter figures and the company's adjusted fiscal 2027 earnings guidance of USD 44.20 to USD 45.00.

What comes next for earnings?

McKesson's chronology is clear. On August 5, 2026, it reported first-quarter fiscal 2027 revenue of USD 105.38 billion; on September 23, 2026, it announced the date for its next results; and on October 6, 2026, it announced the USD 5.8 billion Option Care agreement. The first event is covered by MarketBeat, while the latter dates come from the company releases.

Next date is November 4

The next scheduled event is November 4, 2026, when McKesson will release second-quarter fiscal 2027 results after the market close and hold its earnings call at 4:30 p.m. ET, according to McKesson.

Stock valuation stays elevated

McKesson's primary listing is on the New York Stock Exchange. Its primary-market quote was USD 976.57 at 4:00 p.m. ET on October 14, 2026, while the 52-week range was USD 723.68 to USD 999.00 and market capitalization was USD 113.9 billion. At Lang & Schwarz, McKesson stock was trading at EUR 878.00 on October 15, 2026 at 10:08 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of McKesson stock.

McKesson stock facts

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • Ticker: MCK
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 15, 2026, 10:08 a.m. CEST): EUR 878.00
  • Market capitalization: USD 113.9 billion (as of October 14, 2026)
  • 52-week range: USD 723.68-999.00 (as of October 14, 2026)
  • Sector / Industry: Healthcare services / healthcare distribution

Market context: Market report S&P 500.

More news and analyses on McKesson stock

Disclaimer...
en | US58155Q1031 | MCKESSON | boerse | 70326954 | bgmi